Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8675667 | 0.67 | ALDH1A1 (0.38) | KDM4EMEN1KMT2ATDP1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL8675812 | 0.65 | ALDH1A1 (0.36) | KDM4EMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL7297677 | 0.65 | MAPK1 (0.46) | KDM4EMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL19029861 | 0.60 | CASP1 (0.41) | KDM4EMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL7297946 | 0.60 | — | — | |
| SCHEMBL8677466 | 0.60 | PTPN5 (0.39) | KDM4EMEN1KMT2AALDH1A1TSHR | |
| SCHEMBL20223487 | 0.59 | CA2 (0.37) | ALDH1A1TSHR | |
| SCHEMBL28235815 | 0.59 | FFAR1 (0.48) | KDM4EMEN1KMT2ATDP1ALDH1A1 | |
| SCHEMBL7350411 | 0.59 | — | — | |
| SCHEMBL64498 | 0.57 | TDP1 (0.54) | KDM4EMEN1KMT2ATDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0602209-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| WO-1994001113-A1 | OXYTOCIN ANTAGONIST | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-01-20 | — | — | WO | disclosed |